A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema
NCT04654351
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2
Enrollment
INDUSTRY
Sponsor class
Conditions
Hereditary Angioedema
Interventions
DRUG:
TAK-667
Sponsor
Takeda